Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Charts for Quick CASH $$$ -- Ignore unavailable to you. Want to Upgrade?

To: Galirayo who wrote (7803)	5/20/1998 12:48:00 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 9262

[ chat, news server ] Yahoo feed appears to be toast, and I am therefore missing Business Wire. PRN is working fine....... prnewswire.com ONXX continues to fall. I saw it hit 8 3/8 bid. Just getting ripped. Here's the key release, with a key quote following it...... biz.yahoo.com "the company reported that 30 percent of patients treated with ONYX-015 alone had significant tumor regressions, including two complete regressions in patients with end-stage, treatment-resistant disease." There are real issues facing any company that is using a viral vector to get gene therapy to a cancer. However, these guys are giving it a go, and there are reasonable technical approaches to the hurdles. Cheers! Rick

To: Galirayo who wrote (7803)	5/20/1998 2:36:00 PM
From: scaram(o)uche	Read Replies (3) \| Respond to of 9262

[ Surely you are Joking, Rick ] Well, as long as I have a long leash...... We've discussed the possibility that biotech may finally be emerging from it's long slump. A new pharma was just created, a pharma with huge resources and a pharma with a CEO that has indicated that small biotechs will be the likely target........ biz.yahoo.com To me, this means two things...... (1) that there's more fuel for a biotech rally, and (2) Amgen will be taken out. ONXX...... whack! whack! blam! Cheers! Rick